Search Results 11-20 of 17385 for GLP-1 medications

  1. Semaglutide (oral route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... medicine or any other medicines. ... Do not keep outdated medicine or medicine no longer ...

  2. Liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. Liraglutide injection is also used together with a reduced-calorie diet and proper ...

  3. Preoperative Gastric Content With Ultrasound Assessment in Patients Taking GLP1 Agonists - Mayo Clinic

    ... glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists. Participation eligibility. Participant eligibility ...

  4. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

    Glucagon-like peptide 1 receptor agonists (GLP ... medications. This increased surveillance likely ... These findings should allow clinicians to prescribe these ...

  5. Mayo Clinic Minute: Weaning off popular weight-loss medications

    Journalists: Broadcast-quality video (1:00) is in the downloads at the end of this post. Please courtesy: "Mayo Clinic News Network." Read the script. You ...

  6. Mayo Clinic Minute: Using combined therapy to treat obesity

    Using combined therapy to treat obesity, combining bariatric surgery, also called metabolic surgery, with GLP-1 medications. Learn more.

  7. Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  8. Management of obesity within hepatology clinics - Mayo Clinic

    Anti-obesity medications · Glucagon-like peptide 1 (GLP-1) receptor agonists. These agents can lead to significant weight loss. According to Dr. · Sodium-glucose ...

  9. Contribution of GLP-1 Receptor - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Obesity - Diagnosis and treatment - Mayo Clinic

    Also approved by the FDA is a class of drugs known as glucagonlike peptide 1 agonists, also called GLP-1 agonists. Some of these medicines are approved ...